Kano Therapeutics
Biotechnology
Kano Therapeutics valuation and funding history | Last updated: August 12, 2024 | 2 funding rounds
Current Valuation
N/A
As of August 12, 2024
Total Funding Raised
N/A
Across 2 rounds
Last Round
Seed Round
$5.0M
Last Funding
Aug 2024
Funding date
Capital Efficiency
N/A
Valuation / Funding
Funding History & Valuation Timeline
Complete history of all funding rounds and valuation milestones
| Date | Round | Amount | Post-Valuation | Growth |
|---|---|---|---|---|
| August 12, 2024 | Seed Round | $5.0M | N/A | - |
| May 6, 2022 | Seed Round | $2.1M | N/A | - |
Valuation Analysis
Current Valuation Metrics
Kano Therapeutics is currently valued at N/A as of August 12, 2024.
What is Kano Therapeutics Worth in 2026?
Kano Therapeutics is a leading private company in the Biotechnology sector. Track Kano Therapeutics's valuation history, funding timeline, and implied market value from secondary transactions on Premier Alternatives.
How Kano Therapeutics Valuation is Determined
Private company valuations like Kano Therapeutics's are determined through primary funding rounds led by venture capital firms, private equity investors, and strategic partners. The valuation reflects factors including revenue growth, market opportunity, competitive positioning, and investor sentiment.